Significant Ownership of Slate Path Capital LP

Large-stake snapshot 1 signal
Large-stake filing summary
  • Recent SEC Schedule 13D/G filings for Slate Path Capital LP focus on large-stake beneficial ownership disclosures and amendments.
  • Use this view to spot new large holders, amended positions, and activist-style ownership evidence.
Manager Names, identifiers, and filing context for this profile. 2 identity fields
Manager location
New York, NY
Manager signature
/s/ Thomas Hansen - By: Jades GP, LLC, General Partner, By: Thomas Hansen, Chief Financial Officer and Chief Operating Officer

Follow Filing Activity

Follow Slate Path Capital LP and return when a new Schedule 13D/G filing changes the record on this page.

This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.

Create free account and return here Already have an account? Sign in and return here

Significant Ownership of Slate Path Capital LP

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
WOLF WOLFSPEED, INC. Common Stock, par value $0.00125 per share 10% $106,229,574 6,438,156 Slate Path Capital LP 31 Mar 2026
TVRD Tvardi Therapeutics, Inc. Common stock, par value $0.001 per share 7.5% $19,257,627 704,118 Slate Path Capital LP 30 Jun 2025
RKT Rocket Companies, Inc. Class A common stock, par value $0.00001 per share 2% $375,158,040 19,358,000 Slate Path Capital LP 30 Sep 2025
CUE Cue Biopharma, Inc. Common stock, par value $0.001 per share 1.4% $790,199 918,836 Slate Path Capital LP 31 Dec 2024
CYCN Cyclerion Therapeutics, Inc. Common Stock, no par value 0% $0 0 Slate Path Capital LP 30 Nov 2024

Schedules 13D/G Reported by Slate Path Capital LP:

Sym Target Class Ownership Change Current shares Change Value Reporting name Form Report period Filing date
Schedule rows are parsed from SEC 13D/G filings. Open the linked filing or target page to verify the reported ownership and shares.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .